---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-050333"
form_type: "8-K"
ticker: "AVTR"
cik: "0001722482"
company_name: "Avantor, Inc."
filed_at: "2026-07-29T10:13:52+00:00"
generated_at: "2026-07-29T10:15:04.869583+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Avantor Q2 net sales $1.69B, GAAP EPS $0.06, adj. EPS $0.21; raises FY guidance

## Summary
- Net sales $1,692.3M, up 0.5% reported, organic -0.4%; net income $38.1M vs $64.7M prior year.
- Adjusted EBITDA $254.3M (15.0% margin); adjusted EPS $0.21; operating cash flow $178.2M, free cash flow $142.8M.
- VWR Distribution & Services organic +1.7%; Bioscience & Medtech Products organic -5.6%.
- Updated FY 2026 guidance: organic revenue growth -0.5% to +0.5% (from -2.5% to -0.5%), adjusted EPS $0.80-$0.83.
- Repaid $112.1M debt in Q2; total debt $3,715.4M, cash $306.8M; adjusted net leverage 3.3x.

## SEC filing metadata
- accession: 0001628280-26-050333
- form_type: 8-K
- ticker: AVTR
- cik: 0001722482
- company_name: Avantor, Inc.
- filed_at: 2026-07-29T10:13:52+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1722482/000162828026050333/0001628280-26-050333-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1722482/000162828026050333/avtr-20260729.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-050333
- JSON: https://secwatch.observer/filing/0001628280-26-050333.json
- Plain text: https://secwatch.observer/filing/0001628280-26-050333.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.